← The Wire
BSXNYSE
BOSTON SCIENTIFIC CORP
Surgical & Medical Instruments & Apparatus · DE · CIK 885725
Develops, manufactures, and markets medical devices for various healthcare markets
🔥 High media attention
$69.72B
Market cap
$43.48
Last close
-1.7%
1D
-1.9%
5D
21.9M
Volume
Price · last 39 sessions-23.5%
May 4L $43.48 · H $57.78Jun 29
149
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateMay 18, 20268-KCompany UpdateMay 18, 20268-KBylaw Amendment · Shareholder VoteMay 5, 20268-KResults of OperationsApr 22, 20268-KCompany UpdateMar 30, 20268-KMaterial Agreement · Agreement TerminatedFeb 26, 20268-KExecutive Change · Reg FD DisclosureFeb 23, 20268-KExecutive ChangeFeb 5, 20268-KResults of OperationsFeb 4, 20268-KMaterial AgreementJan 15, 20268-KReg FD DisclosureJan 15, 20268-KExecutive ChangeNov 19, 20258-KExecutive ChangeOct 23, 20258-KResults of OperationsOct 22, 20258-KExecutive ChangeSep 4, 20258-KResults of OperationsJul 23, 20258-KCompany UpdateMay 28, 20258-KShareholder VoteMay 6, 20258-KExecutive Change · Company UpdateApr 23, 20258-KResults of OperationsApr 23, 20258-KMaterial Agreement · New Debt / ObligationFeb 26, 20258-KExecutive ChangeFeb 12, 20258-KResults of OperationsFeb 5, 20258-KCompany UpdateJan 16, 20258-KExecutive ChangeNov 22, 20248-KCompany UpdateNov 15, 20248-KReg FD DisclosureNov 7, 20248-KResults of OperationsOct 23, 20248-KExecutive Change · Reg FD DisclosureJul 30, 20248-KResults of OperationsJul 24, 20248-KExecutive Change · Bylaw AmendmentMay 10, 20248-KBylaw Amendment · Shareholder VoteMay 6, 20248-KResults of OperationsApr 24, 20248-KCompany UpdateApr 4, 20248-KMaterial Agreement · New Debt / ObligationFeb 27, 20248-KExecutive ChangeJan 31, 20248-KResults of OperationsJan 31, 20248-KMaterial AgreementJan 8, 20248-KReg FD DisclosureJan 8, 20248-KExecutive ChangeNov 22, 20238-KResults of OperationsOct 26, 20238-KResults of OperationsJul 27, 20238-KExecutive Change · Reg FD DisclosureJun 27, 20238-KCompany UpdateJun 6, 20238-KShareholder VoteMay 9, 20238-KResults of OperationsApr 26, 20238-KCompany UpdateMar 1, 20238-KResults of OperationsFeb 1, 20238-KExecutive ChangeJan 31, 20238-KExecutive ChangeNov 21, 20228-KResults of OperationsOct 26, 20228-KResults of OperationsJul 27, 20228-KExecutive Change · Shareholder VoteMay 6, 20228-KResults of OperationsApr 27, 20228-KExecutive ChangeApr 5, 20228-KCompany UpdateMar 17, 20228-KMaterial Agreement · New Debt / ObligationMar 8, 20228-KReg FD DisclosureMar 2, 20228-KCompany UpdateFeb 15, 20228-KResults of OperationsFeb 2, 20228-KExecutive ChangeNov 23, 20218-KCompany UpdateNov 9, 20218-KResults of Operations · Security-Holder RightsOct 27, 20218-KCompany UpdateOct 6, 20218-KCompany UpdateSep 21, 20218-KCompany UpdateSep 1, 20218-KResults of OperationsJul 27, 20218-KExecutive Change · Reg FD DisclosureJun 24, 20218-KCompany UpdateJun 24, 20218-KMaterial Agreement · Agreement TerminatedMay 13, 20218-KShareholder VoteMay 11, 20218-KResults of OperationsApr 28, 20218-KExecutive ChangeMar 11, 20218-KCompany UpdateMar 3, 20218-KCompany UpdateMar 1, 20218-KResults of OperationsFeb 3, 20218-KCompany UpdateJan 21, 20218-KResults of OperationsJan 12, 20218-KCompany UpdateDec 14, 20208-KExit / Disposal Costs · Company UpdateDec 1, 2020
Insider Activity
In the 90 days to Feb 2, 2026: 3 sold $18.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | Mahoney Michael FChairman, President & CEO | Sell | 159,701 | $93.49 | $14.9M |
| Feb 2, 2026 | Mahoney Michael FChairman, President & CEO | Sell | 1,200 | $94.06 | $113K |
| Dec 1, 2025 | Butcher Arthur CEVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $101.55 | $1.8M |
| Nov 6, 2025 | Zane Ellen MDirector | Sell | 12,891 | $98.28 | $1.3M |
| Nov 3, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 29,472 | $99.14 | $2.9M |
| Nov 3, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 16,928 | $99.76 | $1.7M |
| Nov 3, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 3,600 | $100.75 | $363K |
| Oct 28, 2025 | Zane Ellen MDirector | Sell | 2,901 | $102.24 | $297K |
| Oct 27, 2025 | Zane Ellen MDirector | Sell | 9,990 | $101.13 | $1.0M |
| Oct 1, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 41,755 | $98.38 | $4.1M |
| Oct 1, 2025 | Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sell | 8,245 | $98.91 | $816K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 6 reputable articles · skews ▼ negative.
MarketWatchBoston Scientific Corp. stock underperforms Monday when compared to competitors15h agoMarketWatchBoston Scientific Corp. stock underperforms Wednesday when compared to competitors12d agoMarketWatchBoston Scientific Corp. stock underperforms Thursday when compared to competitors18d agoMarketWatchBoston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains25d agoFortuneBoston Scientific (BSX): Company Profile, Stock Price, News, Rankings27d agoBarron'sOur Boston Scientific Pick Has Suffered. We’re Pulling the Recommendation.1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance